Mc Ilrath & Eck, LLC Novartis Ag Transaction History

Mc Ilrath & Eck, LLC

$572 Million
Q4 2024

A detailed history of Mc Ilrath & Eck, LLC transactions in Novartis Ag stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 375 shares of NVS stock, worth $41,805. This represents 0.01% of its overall portfolio holdings.

Number of Shares

375

Previous 375 -0.0%

Holding current value

$41,805

Previous $43,000 16.28%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$94.73 - $105.13 $9,473 - $10,513	100 Added 36.36%	375 $38,000
Q2 2023 Aug 07, 2023	SELL	$92.52 - $104.91 $63,468 - $71,968	-686 Reduced 71.38%	275 $27,000
Q1 2023 May 08, 2023	BUY	$80.03 - $92.81 $1,280 - $1,484	16 Added 1.69%	961 $88,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $42,198 - $49,092	516 Added 120.28%	945 $77,000
Q1 2021 May 12, 2021	BUY	$83.5 - $98.47 $4,509 - $5,317	54 Added 14.4%	429 $37,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $4,107 - $4,550	-50 Reduced 11.76%	375 $33,000
Q2 2020 Aug 04, 2020	BUY	$80.93 - $91.1 $1,456 - $1,639	18 Added 4.42%	425 $37,000
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $989 - $1,386	14 Added 3.56%	407 $34,000
Q4 2019 Feb 11, 2020	SELL	$84.35 - $95.37 $1,855 - $2,098	-22 Reduced 5.3%	393 $37,000
Q3 2019 Nov 05, 2019	SELL	$85.54 - $94.26 $8,468 - $9,331	-99 Reduced 19.26%	415 $36,000
Q1 2019 May 07, 2019	BUY	$75.32 - $86.15 $11,599 - $13,267	154 Added 42.78%	514 $49,000
Q4 2018 May 07, 2019	BUY	$73.66 - $82.02 $2,946 - $3,280	40 Added 12.5%	360 $31,000
Q2 2018 Aug 07, 2018	BUY	$64.91 - $73.36 $3,764 - $4,254	58 Added 22.14%	320 $24,000
Q4 2017 Mar 19, 2018	BUY	$72.33 - $77.64 $18,950 - $20,341	262	262 $22,000

Others Institutions Holding NVS

# of Institutions

1,480

Shares Held

130M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $240B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.

Account